Biotech

All Articles

FDA fragments adcomm for Applied's rare illness medicine

.After dismissing the choice meeting for Applied Rehabs' metabolic condition medication govorestat, ...

Novo inks $600M NanoVation bargain to analyze genetic drugs ex-liver

.Novo Nordisk is continuing its press in to genetic medicines, accepting to pay NanoVation Rehabs up...

Innovent links cytokine to colon cancer feedbacks

.Innovent Biologics has made the situation that its gate inhibitor-cytokine fusion healthy protein h...

Merck, Daiichi ADC reaches target in phase 3 bronchi cancer cells research

.A period 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate...

Rakovina strengthens artificial intelligence center along with collab to choose cancer cells aim ats

.5 months after Rakovina Therapies turned toward artificial intelligence, the cancer-focused biotech...

Ascendis' dwarfism medication hits in phase 3, threatens BioMarin

.Ascendis Pharma has become a prospective danger to BioMarin's Voxzogo, disclosing period 3 growth d...

Despite ph. 3 overlook, Alkeus finds course in advance for eye disease resource

.Though Alkeus Pharmaceuticals' oral eye ailment property neglected to significantly minimize geogra...

Kairos goes social with $6M IPO to cash tests of cancer cells medication

.With a trio of biotechs hitting the Nasdaq on Friday, it was actually very easy to miss a smaller-s...

Vaccine as well as Keytruda combination effective in squamous cell carcinoma

.Immune gate preventions are the superheroes of cancer cells treatment. Medications like Bristol Mye...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of considerable leadership hirings, shootin...